Breaking News

Rentschler Biopharma Establishes Cell and Gene CoE

Aims to address the gap in capacity and support for early-stage innovators in cell and gene therapy.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, is establishing a Center of Excellence for cell and gene therapy in Stevenage, UK. The new UK subsidiary, Rentschler ATMP Ltd., will establish development and manufacturing capability in Advanced Therapy Medicinal Products (ATMPs). The site is being set up at an existing facility run by the Cell and Gene Therapy Catapult through a collaboration. Rentschler plans to make a significant investment at the site in the next five years t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters